Physician profile
Benjamin B Chun
NPI 1699747956
$8,535.27
in general payments reported to CMS, 2019-2025
22 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,375 · 2020: $1,001 · 2021: $1,006 · 2022: $860 · 2023: $1,036 · 2024: $1,015 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,280 · Education: $12.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,280.34 |
| Education | $12.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,490.70 | 2019-2022 | |
| Abbvie INC. | $1,438.76 | 2022-2025 | Xen Glaucoma Treatment System, Lumigan, Alphagan P |
| Bausch & Lomb Americas INC. | $1,059.66 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $699.34 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $565.35 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $547.74 | 2019-2025 | Cequa |
| Alcon Vision LLC | $424.88 | 2019-2025 | Clareon, Voyager Dslt, Unity |
| Oyster Point Pharma, INC. | $235.17 | 2022-2024 | Tyrvaya, Ryzumvi |
| New World Medical,INC. | $213.45 | 2019-2023 | |
| Thea Pharma INC. | $129.09 | 2022-2025 | Iyuzeh |
| Mallinckrodt Enterprises LLC | $111.12 | 2019 | |
| Aerie Pharmaceuticals, INC. | $110.37 | 2020-2021 | |
| Sight Sciences, INC. | $104.81 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Kala Pharmaceuticals, INC. | $82.37 | 2020-2021 | |
| Biotissue Holdings INC. | $77.90 | 2021-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $62.63 | 2024-2025 | Iheezo, Vevye |
| Glaukos Corporation | $57.51 | 2024-2025 | Istent Infinite, Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Research LLC | $47.51 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $29.12 | 2024 | Tecnis Simplicity |
| Akorn, INC. | $17.61 | 2020 | |
| Maculogix, INC. | $15.22 | 2021 | |
| Horizon Therapeutics Plc | $14.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Chun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.